131 related articles for article (PubMed ID: 33338262)
21. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
22. Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia.
Aydin O; Dusmez D; Cinel L; Doruk E; Kanik A
Pathol Res Pract; 2002; 198(4):267-71. PubMed ID: 12049335
[TBL] [Abstract][Full Text] [Related]
23. Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion.
Yuan H; Hsiao YH; Zhang Y; Wang J; Yin C; Shen R; Su Y
BMC Cancer; 2013 May; 13():258. PubMed ID: 23705594
[TBL] [Abstract][Full Text] [Related]
24. Differences of the immune cell landscape between normal and tumor tissue in human prostate.
Zhang E; Dai F; Mao Y; He W; Liu F; Ma W; Qiao Y
Clin Transl Oncol; 2020 Mar; 22(3):344-350. PubMed ID: 31077088
[TBL] [Abstract][Full Text] [Related]
25. The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment.
Glajcar A; Szpor J; Pacek A; Tyrak KE; Chan F; Streb J; Hodorowicz-Zaniewska D; Okoń K
Virchows Arch; 2017 May; 470(5):505-515. PubMed ID: 28315938
[TBL] [Abstract][Full Text] [Related]
26. [The distribution of mast cells in benign and malignant prostate lesions and its biologic significance].
Deng WB; Li P; Li GX; Zhao Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):623-5. PubMed ID: 15460402
[TBL] [Abstract][Full Text] [Related]
27. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.
Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y
J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413
[TBL] [Abstract][Full Text] [Related]
28. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
29. Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.
Ellis L; Ku S; Li Q; Azabdaftari G; Seliski J; Olson B; Netherby CS; Tang DG; Abrams SI; Goodrich DW; Pili R
Prostate; 2016 Sep; 76(13):1192-202. PubMed ID: 27225803
[TBL] [Abstract][Full Text] [Related]
30. Mast cell: insight into remodeling a tumor microenvironment.
Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
[TBL] [Abstract][Full Text] [Related]
31. The dark side of mast cell-targeted therapy in prostate cancer.
Pittoni P; Colombo MP
Cancer Res; 2012 Feb; 72(4):831-5. PubMed ID: 22307838
[TBL] [Abstract][Full Text] [Related]
32. Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer.
Zadvornyi T; Lukianova N; Borikun T; Tymoshenko A; Mushii O; Voronina O; Vitruk I; Stakhovskyi E; Chekhun V
Neoplasma; 2022 Dec; 69(6):1490-1498. PubMed ID: 36591806
[TBL] [Abstract][Full Text] [Related]
33. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
34. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
Zhao SG; Lehrer J; Chang SL; Das R; Erho N; Liu Y; Sjöström M; Den RB; Freedland SJ; Klein EA; Karnes RJ; Schaeffer EM; Xu M; Speers C; Nguyen PL; Ross AE; Chan JM; Cooperberg MR; Carroll PR; Davicioni E; Fong L; Spratt DE; Feng FY
J Natl Cancer Inst; 2019 Mar; 111(3):301-310. PubMed ID: 30321406
[TBL] [Abstract][Full Text] [Related]
35. High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot.
Keam SP; Halse H; Nguyen T; Wang M; Van Kooten Losio N; Mitchell C; Caramia F; Byrne DJ; Haupt S; Ryland G; Darcy PK; Sandhu S; Blombery P; Haupt Y; Williams SG; Neeson PJ
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581061
[TBL] [Abstract][Full Text] [Related]
36. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
37. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
[TBL] [Abstract][Full Text] [Related]
38. Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.
Aponte-López A; Fuentes-Pananá EM; Cortes-Muñoz D; Muñoz-Cruz S
J Immunol Res; 2018; 2018():2584243. PubMed ID: 29651440
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor E3, a major regulator of mast cell-mediated allergic response.
Yagil Z; Hadad Erlich T; Ofir-Birin Y; Tshori S; Kay G; Yekhtin Z; Fisher DE; Cheng C; Wong WS; Hartmann K; Razin E; Nechushtan H
J Allergy Clin Immunol; 2012 May; 129(5):1357-1366.e5. PubMed ID: 22360977
[TBL] [Abstract][Full Text] [Related]
40. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
